Impact of endothelial nitric oxide synthase polymorphisms on urothelial cell carcinoma development.

[1]  C. B. Steele,et al.  Surveillance for Cancers Associated with Tobacco Use — United States, 2010–2014 , 2018, Morbidity and mortality weekly report. Surveillance summaries.

[2]  Mu-Kuan Chen,et al.  Associations of genetic variations of the endothelial nitric oxide synthase gene and environmental carcinogens with oral cancer susceptibility and development. , 2018, Nitric oxide : biology and chemistry.

[3]  A. Erez,et al.  Arginine and the metabolic regulation of nitric oxide synthesis in cancer , 2018, Disease Models & Mechanisms.

[4]  Shun-Fa Yang,et al.  Association of endothelial nitric oxide synthase (eNOS) polymorphisms with EGFR-mutated lung adenocarcinoma in Taiwan , 2018, Journal of Cancer.

[5]  Ji-Zheng Qin,et al.  microRNAs regulate nitric oxide release from endothelial cells by targeting NOS3 , 2018, Journal of Thrombosis and Thrombolysis.

[6]  N. Durán,et al.  Nitric oxide donors for prostate and bladder cancers: Current state and challenges , 2018, European journal of pharmacology.

[7]  M. Hou,et al.  Distinct role of endothelial nitric oxide synthase gene polymorphisms from menopausal status in the patients with sporadic breast cancer in Taiwan. , 2018, Nitric oxide : biology and chemistry.

[8]  J. Erdmann,et al.  Association of NOS3 gene polymorphisms with essential hypertension in Sudanese patients: a case control study , 2017, BMC Medical Genetics.

[9]  H. Chiou,et al.  Clinical and demographic characteristics among patients with urothelial carcinomas of the upper urinary tract and bladder in Taiwan , 2017, Journal of the Chinese Medical Association : JCMA.

[10]  Z. Tabka,et al.  The ‐786 T/C polymorphism of NOS3 gene is a susceptibility marker of COPD among Tunisians that correlates with nitric oxide levels and airflow obstruction , 2017, Cytokine.

[11]  A. Hussain,et al.  The Potential Role of Nitric Oxide in Halting Cancer Progression Through Chemoprevention , 2016, Journal of cancer prevention.

[12]  J. Soria,et al.  Novel therapeutic targets in advanced urothelial carcinoma. , 2016, Critical reviews in oncology/hematology.

[13]  Y. Lotan,et al.  Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes. , 2016, European urology.

[14]  A. Donato,et al.  Cellular and molecular biology of aging endothelial cells. , 2015, Journal of molecular and cellular cardiology.

[15]  I. D. de Jong,et al.  Urinary bladder carcinoma: impact of smoking, age and its clinico-pathological spectrum. , 2015, Kathmandu University medical journal.

[16]  K. Kashfi,et al.  The dual role of iNOS in cancer☆ , 2015, Redox biology.

[17]  R. Wahab,et al.  Secondhand Smoking Is Associated With Vascular Inflammation. , 2015, Chest.

[18]  Jianqiong Zhang,et al.  eNOS Genetic Polymorphisms and Cancer Risk , 2015, Medicine.

[19]  Lei Zhang,et al.  The G894t, T‐786c and 4b/a polymorphisms in Enos gene and cancer risk: a meta‐analysis , 2014, Journal of evidence-based medicine.

[20]  Annette Fenner.  Bladder cancer: Microscopic haematuria associated with increased risk , 2014, Nature reviews. Urology.

[21]  S. S. Nishank.  Endothelial Nitric Oxide Synthase (eNOS) Gene Polymorphism is Associated with Age Onset of Menarche in Sickle Cell Disease Females of India , 2013, Mediterranean journal of hematology and infectious diseases.

[22]  L. Cope,et al.  Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma , 2013, Cell cycle.

[23]  David C. Miller,et al.  Quality indicators in the management of bladder cancer. , 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

[24]  Melissa M. Reynolds,et al.  Applications for nitric oxide in halting proliferation of tumor cells. , 2013, Biochemical and biophysical research communications.

[25]  L. Kiemeney,et al.  Epidemiology and risk factors of urothelial bladder cancer. , 2013, European urology.

[26]  N. Kim,et al.  Association of nitric oxide synthase gene polymorphisms (-786T>C, 4a4b, 894G>T) with primary ovarian insufficiency in Korean women. , 2013, Maturitas.

[27]  A. W. Carpenter,et al.  Nitric oxide release: part II. Therapeutic applications. , 2012, Chemical Society reviews.

[28]  U. Förstermann,et al.  Nitric oxide synthases: regulation and function. , 2012, European heart journal.

[29]  T. Nyberg,et al.  Polymorphisms in nitric-oxide synthase 3 may influence the risk of urinary-bladder cancer. , 2011, Nitric oxide : biology and chemistry.

[30]  D. Silverman,et al.  Association between smoking and risk of bladder cancer among men and women. , 2011, JAMA.

[31]  Young Hak Kim,et al.  Genetic polymorphisms in the endothelial nitric oxide synthase gene correlate with overall survival in advanced non-small-cell lung cancer patients treated with platinum-based doublet chemotherapy , 2010, BMC Medical Genetics.

[32]  R. Montiel,et al.  Endothelial nitric oxide synthase (eNOS) 894 G>T polymorphism is associated with breast cancer risk: a meta-analysis , 2010, Breast Cancer Research and Treatment.

[33]  H. Chiou,et al.  A significantly joint effect between arsenic and occupational exposures and risk genotypes/diplotypes of CYP2E1, GSTO1 and GSTO2 on risk of urothelial carcinoma. , 2009, Toxicology and applied pharmacology.

[34]  O. Feron,et al.  Vascular Caveolin Deficiency Supports the Angiogenic Effects of Nitrite, a Major End Product of Nitric Oxide Metabolism in Tumors , 2009, Molecular Cancer Research.

[35]  Liang Cheng,et al.  Staging and reporting of urothelial carcinoma of the urinary bladder , 2009, Modern Pathology.

[36]  G. Gores,et al.  Nitric oxide regulates tumor cell cross-talk with stromal cells in the tumor microenvironment of the liver. , 2008, The American journal of pathology.

[37]  D. Mukhopadhyay,et al.  Nitric oxide promotes endothelial cell survival signaling through S-nitrosylation and activation of dynamin-2 , 2007, Journal of Cell Science.

[38]  R. Jain,et al.  The role of nitric oxide in tumour progression , 2006, Nature Reviews Cancer.

[39]  S. Friedman,et al.  Mechanisms of nitric oxide interplay with Rho GTPase family members in modulation of actin membrane dynamics in pericytes and fibroblasts. , 2005, The American journal of pathology.

[40]  L. Cubeddu,et al.  Endothelial nitric oxide synthase polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in Hispanics , 2005, Journal of Human Hypertension.

[41]  H. Wallerand,et al.  Mutations in TP53, but not FGFR3, in urothelial cell carcinoma of the bladder are influenced by smoking: contribution of exogenous versus endogenous carcinogens. , 2004, Carcinogenesis.

[42]  R. Béliveau,et al.  Down‐regulation of caveolin‐1 in glioma vasculature: Modulation by radiotherapy , 2004, Journal of neuroscience research.

[43]  R. Groszmann,et al.  Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice. , 2003, Cancer cell.

[44]  S. Donnini,et al.  Role of nitric oxide in the modulation of angiogenesis. , 2003, Current pharmaceutical design.

[45]  J. Balligand,et al.  Modifier effect of ENOS in autosomal dominant polycystic kidney disease. , 2002, Human molecular genetics.

[46]  A. Gentilini,et al.  Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells. , 2000, Gastroenterology.

[47]  J. Moss,et al.  Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[48]  S. Brennecke,et al.  Genetic susceptibility to pre-eclampsia and chromosome 7q36 , 1999, Human Genetics.

[49]  K. Nakao,et al.  T-786-->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. , 1999, Circulation.

[50]  F. Murad.  Discovery of Some of the Biological Effects of Nitric Oxide and its Role in Cell Signaling , 1999, Bioscience reports.

[51]  T. Billiar,et al.  Molecular biology of nitric oxide synthases , 1998, Cancer and Metastasis Reviews.

[52]  P. Hainaut,et al.  Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein. , 1997, Cancer research.

[53]  G. Garcı́a-Cardeña,et al.  Endothelial Nitric Oxide Synthase Is Regulated by Tyrosine Phosphorylation and Interacts with Caveolin-1* , 1996, The Journal of Biological Chemistry.

[54]  S. Scherer,et al.  Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. , 1993, The Journal of biological chemistry.

[55]  A. Jemal,et al.  Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. , 2017, European urology.

[56]  F. Polat,et al.  T-786C, G894T, and intron 4 VNTR (4a/b) polymorphisms of the endothelial nitric oxide synthase gene in bladder cancer cases. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[57]  H. Sung,et al.  Impact of the 2009 Taiwan tobacco hazards prevention act on smoking cessation. , 2014, Addiction.

[58]  Baoli Heng,et al.  Association between three eNOS polymorphisms and cancer risk: a meta-analysis. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[59]  S. Hughes,et al.  Prompt diagnosis key in bladder cancer. , 2014, The Practitioner.

[60]  C. Dessy,et al.  Tumorigenesis and Neoplastic Progression Caveolin-1 Is Critical for the Maturation of Tumor Blood Vessels through the Regulation of Both Endothelial Tube Formation and Mural Cell Recruitment , 2007 .

[61]  S. Moncada,et al.  International Union of Pharmacology Nomenclature in Nitric Oxide Research. , 1997, Pharmacological reviews.

[62]  E. Chinje,et al.  Role of nitric oxide in growth of solid tumours: a balancing act. , 1997, Essays in biochemistry.